Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Vol. 33, 08 March 2024
* Author to whom correspondence should be addressed.
This paper provides insight into the key role of the Nucleoside Triphosphate Diphosphohydrolase (NTPDase) family in thrombosis and its therapeutic potential. Thrombosis is an important mechanism to prevent bleeding, but its abnormal formation can lead to serious health problems such as myocardial infarction and stroke. This paper employs the method of literature analysis, obtaining materials through the investigation of previous literature, thereby conducting a literature review on the biochemical characteristics of some members of the NTPDase family. This paper begins with a description of the basic mechanisms of thrombosis and the biochemical characterization of the NTPDase family, including the structure, function, and specific substrate specificity of its members. The NTPDase enzymes regulate platelet activation by hydrolyzing extracellular Adenosine Triphosphate (ATP) and Adenosine Diphosphate (ADP), thereby preventing excessive thrombosis. The article describes in detail the catalytic roles of the NTPDase family members, their relationship to platelets and thrombosis, and discusses their role in regulating platelet function and blood coagulation. Finally, the article identifies NTPDase family members as promising targets for the treatment of thrombosis and explores the possibility of utilizing these enzymes in the clinical prevention and treatment of thrombosis-related diseases, highlighting their therapeutic potential in the control of inflammatory vascular diseases.
NTPDases, thrombosis, P2 receptors
1. Atkinson, B., et al. (2006). “Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets.” Blood Cells Mol Dis 36(2): 217-222.
2. Sévigny, J., et al. (2002). “Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.” Blood 99(8): 2801-2809.
3. Kuku lski, F., et al. (2005). “Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.” Purinergic Signal 1(2): 193-204.
4. Robson, S. C., et al. (2006). “The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.” Purinergic Signal 2(2): 409- 430.
5. Zimmermann, H., et al. (2012). “Cellular function and molecular structure of ecto-nucleotidases.” Purinergic Signal 8(3): 437-502.
6. Weisman GA, Erb L, Garrad RC et al (1998) P2Y nucleotide receptors in the immune system: signaling by a P2Y2 receptor in U937 monocytes. Drug Dev Res 45:222 -228.
7. North RA. Molecular physiology of P2X receptors. Phy siol Rev 2002; 82: 1013-7.
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).